BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently three drug candidates in four ongoing clinical programs in Phase l/ll trials for the treatment of hematological cancer and solid tumors, respectively.

Biotechnology

BioInvent International

BioInvent International's headquarters in Lund, Sweden

Martin Welschof

Ingunn Munch Lindvig

Björn Frendéus

Sylvie Ryckebusch

Marie Moores

Andres Mcallister

Stefan Ericsson

Bernd Seizinger

Kristoffer Bissessar

Thomas Hecht

Martin Pålsson

Vincent Ossipow

Leonard Kruimer

Erik Esveld

Natalie Berner

Nanna Lüneborg

Elin Birgersson

Description

People (9)

Nuria Tallberg

Tina Borg

Ingrid Karlsson

Ivan Strekalovskiy

Nicholas Don-Doncow

Sofie Blomberg

Anna Ejdemo

Edla Lindberg

Sofia von Palffy, PhD

Jobs